Mannatech patent infringement: U.S. Judge grants injunction against Green Life and Xiong Lo

Mannatech, Incorporated (NASDAQ: MTEX - News), a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, obtained a judgment finding that Green Life, LLC (Green Life), and Xiong Lo (Lo) infringed Mannatech patents (U.S. Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220).

Senior United States District Judge A. Joe Fish in the U.S. District Court for the Northern District of Texas, Dallas Division, issued a final judgment that entered a broad permanent injunction against Green Life and Lo prohibiting them from “making, using, offering to sell, selling, or otherwise distributing within the United States, or importing into the United States, defendant’s product, Glyco 8, as well as products that are substantially equivalent in composition to Glyco 8, and any other products that infringe the patents in suit.”

“This case underscores our commitment to pursuing injustice against the company and our core technologies. We will continue to do what is necessary to protect our intellectual property,” said Keith Clark, Mannatech’s executive vice president and chief legal officer.

On July 15, Mannatech filed a complaint for patent infringement alleging that Green Life and Xiong Lo infringed Mannatech’s patents entitled “Compositions of Plant Technology as Dietary Supplements,” through Green Life’s purchase of the dietary supplement Glyco 8 from defendant Boston Mountain Laboratories, Inc. Mannatech also named Boston Mountain, the entity that actually manufactured the infringing product, as a defendant. Mannatech previously settled its claims against Boston Mountain through the entry of an agreed final judgment that enjoined Boston Mountain from manufacturing all products infringing on Mannatech patents in question.

Mannatech offers a comprehensive approach to wellness that addresses physical and financial health with cutting-edge, proprietary products based on the foundation of nutritional science and business opportunities for individuals around the world who seek purpose, financial freedom and a chance to impact the lives of others. The company has distinguished itself in the emerging glyconutrients market through the development of Ambrotose^® complex, the technology for which it holds more than 45 patents in 30 countries. Glyconutrients are dietary ingredients containing beneficial amounts of carbohydrates which are believed to represent a new category of untapped vital nutrients for proper nutrition.